![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: FAM25A |
Gene summary for FAM25A |
![]() |
Gene information | Species | Human | Gene symbol | FAM25A | Gene ID | 643161 |
Gene name | family with sequence similarity 25 member A | |
Gene Alias | bA96C23.5 | |
Cytomap | 10q23.2 | |
Gene Type | protein-coding | GO ID | NA | UniProtAcc | B3EWG3 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
643161 | FAM25A | C04 | Human | Oral cavity | OSCC | 1.83e-03 | 2.23e-01 | 0.2633 |
643161 | FAM25A | LP15 | Human | Oral cavity | LP | 8.35e-03 | 3.04e-01 | 0.2174 |
643161 | FAM25A | SYSMH3 | Human | Oral cavity | OSCC | 2.21e-25 | 5.12e-01 | 0.2442 |
643161 | FAM25A | SYSMH4 | Human | Oral cavity | OSCC | 1.59e-05 | 1.03e-01 | 0.1226 |
643161 | FAM25A | SYSMH5 | Human | Oral cavity | OSCC | 1.38e-24 | 5.49e-01 | 0.0647 |
Page: 1 |
![]() |
Tissue | Expression Dynamics | Abbreviation |
Oral Cavity | ![]() | EOLP: Erosive Oral lichen planus |
LP: leukoplakia | ||
NEOLP: Non-erosive oral lichen planus | ||
OSCC: Oral squamous cell carcinoma |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Stomach | WIM | ![]() |
Stomach | SIM | ![]() |
Liver | NAFLD | ![]() |
Liver | Cirrhotic | ![]() |
Liver | HCC | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
FAM25A | SNV | Missense_Mutation | c.31N>A | p.Glu11Lys | p.E11K | B3EWG3,B3EWG4 | protein_coding | tolerated_low_confidence(0.07) | possibly_damaging(0.81) | TCGA-AA-3510-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
FAM25A | SNV | Missense_Mutation | novel | c.54N>T | p.Glu18Asp | p.E18D | B3EWG3,B3EWG4 | protein_coding | deleterious_low_confidence(0.02) | possibly_damaging(0.801) | TCGA-A5-A2K5-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
FAM25A | SNV | Missense_Mutation | novel | c.181N>G | p.Lys61Glu | p.K61E | B3EWG3,B3EWG4 | protein_coding | deleterious_low_confidence(0.02) | benign(0.077) | TCGA-AJ-A3EL-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
FAM25A | SNV | Missense_Mutation | c.31G>A | p.Glu11Lys | p.E11K | B3EWG3,B3EWG4 | protein_coding | tolerated_low_confidence(0.07) | possibly_damaging(0.81) | TCGA-AJ-A5DW-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
FAM25A | SNV | Missense_Mutation | novel | c.149N>T | p.Ala50Val | p.A50V | B3EWG3,B3EWG4 | protein_coding | tolerated_low_confidence(0.2) | benign(0.003) | TCGA-B5-A3FA-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
FAM25A | SNV | Missense_Mutation | novel | c.230T>A | p.Ile77Asn | p.I77N | B3EWG3,B3EWG4 | protein_coding | deleterious_low_confidence(0) | benign(0.106) | TCGA-DI-A1BU-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Chemotherapy | paclitaxel | SD |
FAM25A | SNV | Missense_Mutation | novel | c.148G>T | p.Ala50Ser | p.A50S | B3EWG3,B3EWG4 | protein_coding | deleterious_low_confidence(0.01) | benign(0.08) | TCGA-EO-A22R-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
FAM25A | SNV | Missense_Mutation | novel | c.183G>T | p.Lys61Asn | p.K61N | B3EWG3,B3EWG4 | protein_coding | deleterious_low_confidence(0.01) | benign(0.113) | TCGA-EO-A3B0-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD |
Page: 1 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |